| Sativex oromucosal spray PA25377/001/001 |
Delta-9-tetrahydrocannabinol botanical drug substance (thc bds), CANNABIDIOL |
CNX Therapeutics Ireland Limited |
Marketed |
| Savene 20 mg/ml powder and solvent for concentrate for solution for infusion EU/1/06/350/001 |
Dexrazoxane |
CNX Therapeutics Ireland Limited |
— |
| Saxenda 6 mg/ml solution for injection in pre-filled pen EU/1/15/992/001-003 |
Liraglutide |
Novo Nordisk A/S |
— |
| Scemblix 20 mg film-coated tablets EU/1/22/1670/001-002 |
Asciminib hydrochloride |
Novartis Europharm Limited |
— |
| Scemblix 40 mg film-coated tablets EU/1/22/1670/003-004 |
Asciminib hydrochloride |
Novartis Europharm Limited |
— |
| SCENESSE 16 mg implant EU/1/14/969/001 |
Afamelanotide |
Clinuvel Europe Limited |
— |
| Scintimun 1 mg kit for radiopharmaceutical preparation EU/1/09/602/1-2 |
Besilesomab |
Telix Innovations |
— |
| Seebri Breezhaler 44 micrograms inhalation powder, hard capsules EU/1/12/788/001-006 |
Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Seffalair Spiromax 12.75 micrograms/100 micrograms inhalation powder EU/1/21/1533/001-002 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Teva B.V. |
— |
| Seffalair Spiromax 12.75 micrograms/202 micrograms inhalation powder EU/1/21/1533/003-004 |
SALMETEROL XINAFOATE, Fluticasone propionate |
Teva B.V. |
— |
| Segluromet 2.5 mg/1 000 mg film-coated tablets EU/1/18/1265/008-014 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Segluromet 2.5 mg/850 mg film-coated tablets EU/1/18/1265/001-007 |
Metformin Hydrochloride, Ertugliflozin l-pyroglutamic acid |
Merck Sharp & Dohme BV |
— |
| Segluromet 7.5 mg/1 000 mg film-coated tablets EU/1/18/1265/022-028 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Segluromet 7.5 mg/850 mg film-coated tablets EU/1/18/1265/015-021 |
Ertugliflozin l-pyroglutamic acid, Metformin Hydrochloride |
Merck Sharp & Dohme BV |
— |
| Selincro 18 mg film-coated tablets EU/1/12/815/001-005 |
Nalmefene |
H. Lundbeck A/S |
— |
| Semglee 100 units/ml solution for injection in pre-filled pen EU/1/18/1270/001-004 |
Insulin glargine |
Biosimilar Collaborations Ireland Limited |
— |
| Senshio 60 mg Film-coated tablet EU/1/14/978/001-002 |
Ospemifene |
Shionogi B.V. |
— |
| Sephience 1 000 mg oral powder in sachet EU/1/25/1939/002 |
Sepiapterin |
PTC Therapeutics International Limited |
— |
| Sephience 250 mg oral powder in sachet EU/1/25/1939/001 |
Sepiapterin |
PTC Therapeutics International Limited |
— |
| Septabene eucalyptus 3 mg/1 mg lozenges PA1347/063/001 |
BENZYDAMINE HYDROCHLORIDE, Cetylpyridinium chloride |
KRKA, d.d., Novo mesto |
Not marketed |
| Sereflo 25 microgram/125 microgram per actuation pressurised inhalation, suspension PA1963/013/001 |
Fluticasone propionate, Salmeterol |
Cipla Europe NV |
Not marketed |
| Sereflo 25 microgram/250 microgram per actuation pressurised inhalation, suspension PA1963/013/002 |
Fluticasone propionate, Salmeterol |
Cipla Europe NV |
Not marketed |
| Seretide 250 Diskus 50 microgram/250 microgram/dose inhalation powder, pre-dispensed PPA23080/028/001 |
Salmeterol, Fluticasone propionate |
Merit Pharmaceuticals Limited |
— |
| Seretide 500 Diskus 50 microgram/500 microgram/dose inhalation powder, pre-dispensed PPA23080/028/002 |
Salmeterol, Fluticasone propionate |
Merit Pharmaceuticals Limited |
— |
| Sertraline Bluefish 100 mg film-coated tablets PA1436/021/002 |
Sertraline |
Bluefish Pharmaceuticals AB |
Marketed |
| Sertraline Bluefish 50 mg film-coated tablets PA1436/021/001 |
Sertraline |
Bluefish Pharmaceuticals AB |
Marketed |
| Sevelamer carbonate Winthrop 0.8 g powder for oral suspension EU/1/14/952/005-006 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 2.4 g powder for oral suspension EU/1/14/952/002-003 |
Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer carbonate Winthrop 800 mg film-coated tablets EU/1/14/952/001 |
Sevelamer carbonate, Sevelamer carbonate |
Sanofi Winthrop Industrie |
— |
| Sevelamer Hydrochloride Zentiva EU/1/14/953/001 |
Sevelamer hydrochloride |
Sanofi B.V. |
— |
| Sevredol 10mg Film-Coated Tablets PA1688/009/001 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Sevredol 20 mg Film-Coated Tablets PA1688/009/002 |
Morphine sulfate |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Shingrix powder and suspension for suspension for injection. Herpes zoster vaccine (recombinant, adjuvanted). EU/1/18/1272/001-002 |
Recombinant varicella zoster virus surface glycoprotein e |
GlaxoSmithKline Biologicals S.A. |
— |
| Sialanar 320 micrograms/ml oral solution EU/1/16/1135/001 |
Glycopyrronium bromide |
Proveca Pharma Limited |
— |
| Sibnayal 24 mEq prolonged-release granules EU/1/20/1517/007-012 |
Potassium citrate, Potassium hydrogen carbonate |
Advicenne Pharma SA |
— |
| Sibnayal 8 mEq prolonged-release granules EU/1/20/1517/001-006 |
Potassium citrate, Potassium hydrogen carbonate |
Advicenne Pharma SA |
— |
| SIFROL 0.088 mg tablets EU/1/97/050/001-002 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.18 mg tablets EU/1/97/050/003-004 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.26 mg prolonged-release tablets EU/1/97/050/013-015 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.35 mg tablets EU/1/97/050/011-012 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.52 mg prolonged-release tablets EU/1/97/050/016-018 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 0.7 mg tablets EU/1/97/050/005-006 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.05 mg prolonged-release tablets EU/1/97/050/19-21 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 1.57 mg prolonged-release tablets EU/1/97/050/028-30 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.1 mg prolonged-release tablets EU/1/97/050/22-24 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 2.62 mg prolonged-release tablets EU/1/97/050/031-33 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| SIFROL 3.15 mg prolonged-release tablets EU/1/97/050/25-27 |
Pramipexole dihydrochloride monohydrate |
Boehringer Ingelheim International GmbH |
— |
| Signifor 0.3 mg solution for injection EU/1/12/753/001-004 |
Pasireotide disapartate |
Recordati Rare Diseases |
— |
| Signifor 0.6 mg solution for injection EU/1/12/753/005-008 |
Pasireotide disapartate |
Recordati Rare Diseases |
— |
| Signifor 0.9 mg solution for injection EU/1/12/753/009-012 |
Pasireotide disapartate |
Recordati Rare Diseases |
— |